Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCT
2024-511568-96-00Phase 4Authorised
- Sponsor
- Erasmus MC
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised trial in Autism Spectrum Disorder (ASD) comparing Aripiprazole arm with Risperidone arm (2 arms). Planned start Jul 2024; status: authorised.
02
Drugs
aripiprazolerisperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on 2024-511568-96-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511568-96-00.